Vaxcyte, Inc. (PCVX)
62.03
-0.58
(-0.93%)
USD |
NASDAQ |
Oct 30, 16:00
62.02
-0.02
(-0.02%)
After-Hours: 20:00
Vaxcyte Cash and Short Term Investments (Annual) : 1.561B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.561B |
| December 31, 2024 | 1.747B |
| December 31, 2023 | 1.080B |
| December 31, 2022 | 931.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 245.97M |
| December 31, 2020 | 386.20M |
| December 31, 2019 | 58.98M |
| December 31, 2018 | 66.09M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Moderna, Inc. | 5.80B |
| Vir Biotechnology, Inc. | 468.94M |
| Anavex Life Sciences Corp. | 102.58M |
| Revolution Medicines, Inc. | 2.026B |
| Foghorn Therapeutics, Inc. | 160.14M |